{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:14:49Z","timestamp":1777630489423,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.yexcr.2026.114970","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:03:27Z","timestamp":1772093007000},"page":"114970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b1-synuclein preformed fibrils suppress cell cycle progression and glycolytic flux in glioblastoma cells"],"prefix":"10.1016","volume":"457","author":[{"given":"Hyo-Jin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3608-3863","authenticated-orcid":false,"given":"Hyeonwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Kyung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Seok","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-3163","authenticated-orcid":false,"given":"Sangjune","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2200-7396","authenticated-orcid":false,"given":"Do-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.114970_bib1","first-page":"697","article-title":"Parkinson's disease and cancer risk: a systematic review and meta-analysis","volume":"21","author":"Bajaj","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.yexcr.2026.114970_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"Catala-Lopez","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.yexcr.2026.114970_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-015-0043-z","article-title":"The associations between Parkinson's disease and cancer: the plot thickens","volume":"4","author":"Feng","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.yexcr.2026.114970_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fneur.2020.00898","article-title":"Bidirectional relation between Parkinson's disease and glioblastoma multiforme","volume":"11","author":"Mencke","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.yexcr.2026.114970_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2026.114970_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","article-title":"Transmission of alpha-synuclein seeds in neurodegenerative disease: recent developments","volume":"99","author":"Karpowicz","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2026.114970_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.yexcr.2026.114970_bib8","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2026.114970_bib9","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2026.114970_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.yexcr.2026.114970_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","article-title":"Fibrillar alpha-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-kappaB","volume":"12","author":"Chou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.114970_bib12","article-title":"Therapeutic functions of astrocytes to treat alpha-synuclein pathology in Parkinson's disease","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2026.114970_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4161\/cbt.4.9.2165","article-title":"Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi\/melanoma in situ and advanced-stage melanomas","volume":"4","author":"Smith","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2026.114970_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061417","article-title":"Spreading of alpha synuclein from glioblastoma cells towards astrocytes correlates with stem-like properties","volume":"14","author":"Ryskalin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2026.114970_bib15","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1093\/brain\/awae222","article-title":"Gba1 E326K renders motor and non-motor symptoms with pathological alpha-synuclein, tau and glial activation","volume":"147","author":"Kweon","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.yexcr.2026.114970_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.stemcr.2017.12.001","article-title":"Pathological endogenous alpha-Synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy","volume":"10","author":"Kaji","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.yexcr.2026.114970_bib17","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.yexcr.2026.114970_bib18","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1158\/0008-5472.CAN-09-0913","article-title":"Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells","volume":"69","author":"Masamha","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.114970_bib19","first-page":"481","article-title":"Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy","volume":"30","author":"Liang","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2026.114970_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41389-020-00253-3","article-title":"Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells","volume":"9","author":"Caillot","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexcr.2026.114970_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.114970_bib22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00204-015-1520-y","article-title":"Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism","volume":"89","author":"Liemburg-Apers","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yexcr.2026.114970_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103335","article-title":"Oxidative stress promotes oral carcinogenesis via Thbs1-mediated M1-like tumor-associated macrophages polarization","volume":"76","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2026.114970_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-8-32","article-title":"The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells","volume":"8","author":"Shi","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.114970_bib25","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8559","article-title":"Anti-tumor properties of FoxO1 in YD-9 oral squamous cell carcinoma cells","volume":"49","author":"Kim","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2026.114970_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/1541-7786.MCR-17-0492","article-title":"Foxo-dependent Par-4 upregulation prevents long-term survival of residual cells following PI3K-Akt inhibition","volume":"16","author":"Damrauer","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.114970_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.2008.03681.x","article-title":"Parkinson's disease and cancer: insights for pathogenesis from epidemiology","volume":"1155","author":"D'Amelio","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.yexcr.2026.114970_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0960-9776(03)00061-4","article-title":"Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease","volume":"12","author":"Lalonde","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.yexcr.2026.114970_bib29","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-21-2647","article-title":"Cancer signaling drives cancer metabolism: AKT and the warburg effect","volume":"81","author":"Hosios","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.114970_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bab.2104","article-title":"The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation","volume":"69","author":"Kma","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.yexcr.2026.114970_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918755391","article-title":"Reactive oxygen species: a key constituent in cancer survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.yexcr.2026.114970_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.114970_bib33","first-page":"999","article-title":"High PD-L1 expression drives glycolysis via an Akt\/mTOR\/HIF-1alpha axis in acute myeloid leukemia","volume":"43","author":"Ma","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2026.114970_bib34","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201219RR","article-title":"LDHA deficiency inhibits trophoblast proliferation via the PI3K\/AKT\/FOXO1\/CyclinD1 signaling pathway in unexplained recurrent spontaneous abortion","volume":"37","author":"Zhu","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2026.114970_bib35","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1210\/me.2006-0118","article-title":"Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization","volume":"20","author":"Kajihara","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yexcr.2026.114970_bib36","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","article-title":"Akt, FoxO and regulation of apoptosis","volume":"1813","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2026.114970_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115051","article-title":"Oxaloacetate promotes the transition from glycolysis to gluconeogenesis through the Akt-FoxO1 and JNK\/c-Jun-FoxO1 axes and inhibits the survival of liver cancer cells","volume":"161","author":"Miao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2026.114970_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41419-025-07509-z","article-title":"\u03b1-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance","volume":"16","author":"Duplan","year":"2025","journal-title":"Cell Death Dis."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272600087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272600087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:57:36Z","timestamp":1777431456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448272600087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S001448272600087X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.114970","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-synuclein preformed fibrils suppress cell cycle progression and glycolytic flux in glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.114970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114970"}}